BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33359650)

  • 1. Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication.
    Marcellini A; Swieboda D; Guedán A; Farrow SN; Casolari P; Contoli M; Johnston SL; Papi A; Solari R
    Eur J Pharmacol; 2021 Feb; 893():173839. PubMed ID: 33359650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses.
    Bochkov YA; Busse WW; Brockman-Schneider RA; Evans MD; Jarjour NN; McCrae C; Miller-Larsson A; Gern JE
    Respir Res; 2013 Oct; 14(1):98. PubMed ID: 24219422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
    Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
    Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro.
    Davies JM; Carroll ML; Li H; Poh AM; Kirkegard D; Towers M; Upham JW
    PLoS One; 2011; 6(11):e27898. PubMed ID: 22125636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.
    Cakebread JA; Xu Y; Grainge C; Kehagia V; Howarth PH; Holgate ST; Davies DE
    J Allergy Clin Immunol; 2011 May; 127(5):1148-54.e9. PubMed ID: 21329968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.
    Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N
    Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD.
    Baines KJ; Hsu AC; Tooze M; Gunawardhana LP; Gibson PG; Wark PA
    Respir Res; 2013 Feb; 14(1):15. PubMed ID: 23384071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanosterol Synthase Regulates Human Rhinovirus Replication in Human Bronchial Epithelial Cells.
    McCrae C; Dzgoev A; Ståhlman M; Horndahl J; Svärd R; Große A; Großkopf T; Skujat MA; Williams N; Schubert S; Echeverri C; Jackson C; Guedán A; Solari R; Vaarala O; Kraan M; Rådinger M
    Am J Respir Cell Mol Biol; 2018 Dec; 59(6):713-722. PubMed ID: 30084659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
    Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
    Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.
    Skevaki CL; Christodoulou I; Spyridaki IS; Tiniakou I; Georgiou V; Xepapadaki P; Kafetzis DA; Papadopoulos NG
    Clin Exp Allergy; 2009 Nov; 39(11):1700-10. PubMed ID: 19549024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.
    Porter JD; Watson J; Roberts LR; Gill SK; Groves H; Dhariwal J; Almond MH; Wong E; Walton RP; Jones LH; Tregoning J; Kilty I; Johnston SL; Edwards MR
    J Antimicrob Chemother; 2016 Oct; 71(10):2767-81. PubMed ID: 27494903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
    Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.
    Yamaya M; Nishimura H; Deng X; Sugawara M; Watanabe O; Nomura K; Shimotai Y; Momma H; Ichinose M; Kawase T
    Respir Investig; 2020 May; 58(3):155-168. PubMed ID: 32094077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells.
    Contoli M; Ito K; Padovani A; Poletti D; Marku B; Edwards MR; Stanciu LA; Gnesini G; Pastore A; Spanevello A; Morelli P; Johnston SL; Caramori G; Papi A
    Allergy; 2015 Aug; 70(8):910-20. PubMed ID: 25858686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β
    Wang MT; Lai JH; Huang YL; Liou JT; Cheng SH; Lin CW; Pan HY; Hsu YJ; Tsai CL
    Chest; 2021 Oct; 160(4):1255-1270. PubMed ID: 34023320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation.
    Kuo CH; Yang SN; Tsai YG; Hsieh CC; Liao WT; Chen LC; Lee MS; Kuo HF; Lin CH; Hung CH
    Pulm Pharmacol Ther; 2018 Feb; 48():37-45. PubMed ID: 28987803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of long-acting β
    Kim Y; Hou V; Huff RD; Aguiar JA; Revill S; Tiessen N; Cao Q; Miller MS; Inman MD; Ask K; Doxey AC; Hirota JA
    Respir Res; 2021 Oct; 22(1):266. PubMed ID: 34666750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expression of ephrinA1/ephA2 Receptor Increases in Chronic Rhinosinusitis and ephrinA1/ephA2 Signaling Affects Rhinovirus-Induced Innate Immunity in Human Sinonasal Epithelial Cells.
    Lee SH; Kang SH; Han MS; Kwak JW; Kim HG; Lee TH; Lee DB; Kim TH
    Front Immunol; 2021; 12():793517. PubMed ID: 34975898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling.
    Baturcam E; Vollmer S; Schlüter H; Maciewicz RA; Kurian N; Vaarala O; Ludwig S; Cunoosamy DM
    Cell Commun Signal; 2019 Jul; 17(1):78. PubMed ID: 31319869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection.
    Girkin JL; Hatchwell LM; Collison AM; Starkey MR; Hansbro PM; Yagita H; Foster PS; Mattes J
    Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L89-L99. PubMed ID: 27836899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.